Collaboration and Supply Agreement Sample Contracts
EXHIBIT 10.66 COLLABORATION AND SUPPLY AGREEMENTCollaboration and Supply Agreement • March 15th, 2004 • Caliper Life Sciences Inc • Laboratory analytical instruments • California
Contract Type FiledMarch 15th, 2004 Company Industry Jurisdiction
Standard Contracts
Collaboration and Supply Agreement between Marinus Pharmaceuticals, Inc. and Tenacia Biotechnology (Shanghai) Co., Ltd.Collaboration and Supply Agreement • March 9th, 2023 • Marinus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 9th, 2023 Company Industry JurisdictionThis COLLABORATION AND SUPPLY AGREEMENT is made and entered into as of November 16, 2022 (“Effective Date”) between Marinus Pharmaceuticals, Inc. (“Marinus”), a Delaware corporation with principal offices at 5 Radnor Corporate Center, Suite 500, 100 Matsonford Road, Radnor, Pennsylvania 19087 USA, and Tenacia Biotechnology (Shanghai) Co., Ltd. (“Company”), a company organized and existing under the laws of PRC, located at Room 368, Part 302, 211 North Fute Road, China (Shanghai) Pilot Free Trade Zone. Marinus and Company may be referred herein individually as a “Party” or collectively as the “Parties.”
COLLABORATION AND SUPPLY AGREEMENT by and between RayzeBio, Inc. And Niowave, Inc.Collaboration and Supply Agreement • February 11th, 2022 • RayzeBio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 11th, 2022 Company Industry JurisdictionThis Collaboration and Supply Agreement (this “Agreement”) dated as of May 26, 2021 (the “Effective Date”), by and between RayzeBio, Inc., a Delaware corporation having a place of business at 9880 Campus Point Dr, Suite 410, San Diego, CA 92121 (“RayzeBio”), and Niowave, Inc., a Michigan corporation having a place of business at 1012 N. Walnut Street, Lansing, MI 48906, USA (“Niowave”).
COLLABORATION AND SUPPLY AGREEMENTCollaboration and Supply Agreement • February 13th, 2009 • Dor Biopharma Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledFebruary 13th, 2009 Company Industry JurisdictionDOR BioPharma Inc., a Delaware corporation having its principal office at 850 Bear Tavern Road, Suite 201, Ewing, New Jersey 08628 (the “COMPANY”), and Enteron Pharmaceuticals, Inc., a wholly owned subsidiary of the COMPANY, (“ENTERON”, and together with the COMPANY, “DOR”), each
SGBlocks Collaboration and Supply AgreementCollaboration and Supply Agreement • January 13th, 2012 • Sg Blocks, Inc. • Wholesale-lumber & other construction materials • Missouri
Contract Type FiledJanuary 13th, 2012 Company Industry JurisdictionThis agreement (“Agreement”) is dated as of July 23, 2007, and is made between SGBlocks, LLC, a Missouri limited liability company (“SGB”) and ConGlobal Industries, Inc., a Delaware corporation (“CGI”).
AMENDMENT TO THE COLLABORATION AND SUPPLY AGREEMENT BETWEEN SOLIGENIX, INC., ENTERON PHARMACEUTICALS, INC. AND SIGMA-TAU PHARMACEUTICALS, INC.Collaboration and Supply Agreement • July 28th, 2011 • Soligenix, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2011 Company IndustryThis amendment (the "Amendment") is entered into effective as of the 26th day of July, 2011 (the “Amendment Effective Date”) by and between, on the one hand, Soligenix, Inc. (formerly known as DOR BioPharma, Inc.), a Delaware corporation (“SOLIGENIX”), Enteron Pharmaceuticals, Inc., a Delaware corporation a wholly-owned subsidiary of Soligenix (“Enteron”, and together with Soligenix, the “Company”) and on the other hand, Sigma-Tau Pharmaceuticals, Inc. (“Sigma-Tau”).
COLLABORATION AND SUPPLY AGREEMENTCollaboration and Supply Agreement • March 9th, 2021 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 9th, 2021 Company Industry JurisdictionThis Collaboration and Supply Agreement (“Agreement”) is made and entered into as of May 15, 2018 (the “Effective Date”) by and between Eiger BioPharmaceuticals, Inc., a Delaware corporation having a place of business at 350 Cambridge Avenue, Suite 350, Palo Alto, CA 94306 (“Eiger”), and The Progeria Research Foundation, Inc., a 501(c)(3) not-for-profit organization currently located at 200 Lake St., Peabody MA 01960 (“PRF”). Eiger and PRF are individually referred to as a “Party” and collectively referred to as the “Parties.”
Collaboration AND Supply AgreementCollaboration and Supply Agreement • August 10th, 2018 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 10th, 2018 Company Industry JurisdictionThis Collaboration and Supply Agreement (“Agreement”) is made and entered into as of May 15, 2018 (the “Effective Date”) by and between Eiger BioPharmaceuticals, Inc., a Delaware corporation having a place of business at 350 Cambridge Avenue, Suite 350, Palo Alto, CA 94306 (“Eiger”), and The Progeria Research Foundation, Inc., a 501(c)(3) not-for-profit organization currently located at 200 Lake St., Peabody MA 01960 (“PRF”). Eiger and PRF are individually referred to as a “Party” and collectively referred to as the “Parties.”
AMENDMENT NO. 2 TO THE COLLABORATION AND SUPPLY AGREEMENT BETWEEN SOLIGENIX, INC., ENTERON PHARMACEUTICALS, INC. and SIGMA-TAU PHARMACEUTICALS, INC.Collaboration and Supply Agreement • December 27th, 2012 • Soligenix, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 27th, 2012 Company IndustryThis Amendment no.2 ("Amendment") is entered into effective as of the 20th day of December, 2012 (the “Amendment Effective Date”) by and between, on the one hand, Soligenix, Inc. (formerly known as DOR BioPharma, Inc.), a Delaware corporation (“SOLIGENIX”), Enteron Pharmaceuticals, Inc., a Delaware corporation a wholly-owned subsidiary of Soligenix (“Enteron”, and together with Soligenix, the “Company”) and on the other hand, Sigma-Tau Pharmaceuticals, Inc. (“Sigma-Tau”).
Amendment No. 1 to the Collaboration and Supply AgreementCollaboration and Supply Agreement • August 6th, 2020 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2020 Company IndustryThis Amendment No. 1 (“Amendment”) is effective as of June 15, 2020 (the “Amendment Effective Date”) by and between Eiger BioPharmaceuticals, Inc., a Delaware corporation currently located at 2155 Park Boulevard, Palo Alto, CA 94306 (“Eiger”), and The Progeria Research Foundation, Inc., a 501(c)(3) not-for-profit organization currently located at 200 Lake St., Peabody MA 01960 (“PRF”) and amends the Collaboration and Supply Agreement, dated May 15, 2018, by and between Eiger and PRF (“Agreement”). Certain capitalized terms used herein but not expressly defined in this Amendment will have the meanings given in the Agreement.